|
|
| Line 28: |
Line 28: |
| <span style="display:none">availableVariable::screening</span> | | <span style="display:none">availableVariable::screening</span> |
| <span style="display:none">availableVariable::diagnosis</span> | | <span style="display:none">availableVariable::diagnosis</span> |
| | <span style="display:none">isPracticeGuideline</span> |
| <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | | <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> |
| <span style="display:none">isPracticeGuideline</span>
| |
| <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> |
| <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> |
| <span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
| |
| <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
| |
| <span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
| |
| <span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
| |
| <span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
| |
| <span style="display:none">hasCancerType::C50: Breast cancer</span>
| |
| <span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
| |
| <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
| |
| <span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
| |
| <span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
| |
| <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
| |
| <span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
| |
| <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
| |
| <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
| |
| <span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
| |
| <span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
| |
| <span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
| |
| <span style="display:none">hasCancerType::unknown</span>
| |
forproviders forpolicymakers
portugalcountry isPracticeGuideline
Go back to Portugal page
Primary purpose: To provide national recommendations on various aspects of gastrointestinal endoscopy and treatment procedures.
Sponsor, manager or home institution: Sociedade Portuguesa de Endoscopia Digestiva - SPED.
Type of information: Detailed information on diagnostic and therapeutic approaches, procedural recommendations, and clinical management strategies related to gastrointestinal conditions and endoscopic procedures. medical procedures, screening, diagnosis. Click here to learn more.
Cancer Areas of Interest: C15-C26: Digestive system cancers. Click here to learn more.
Access to information: Click here to access.
Esophagus
Stomach
Small intestine
Large intestine
Rectum
Anus
Liver
Gallbladder
Bile ducts
Pancreas
Colon
dataOwner::Sociedade Portuguesa de Endoscopia Digestiva - SPED
availableVariable::medical procedures
availableVariable::screening
availableVariable::diagnosis
isPracticeGuideline
hasCancerType::C15-C26: Digestive system cancers
hasCancerType::C00-D48: All neoplasms
hasCancerType::C00-C97: All cancer types
